Search for: "Schering-Plough"
Results 1 - 20
of 411
Sorted by Relevance
|
Sort by Date
11 Mar 2009, 6:30 am
Merck filed the agreement for its acquisition of Schering-Plough with regulators on Tuesday. [read post]
12 Mar 2007, 5:49 am
The deal bulks up United States-based Schering-Plough, whose chief executive has made no secret of his desire to find acquisitions. [read post]
14 Nov 2008, 1:15 pm
Schering-Plough also apparently hoped to cut off movement by shareholders toward a more formal say on pay authority. [read post]
21 Jul 2008, 11:03 am
Schering-Plough stock is down over 10% in heavy trading today.What happened? [read post]
9 Mar 2009, 9:52 pm
Based on the March 6, 2009 closing price of Merck stock, Schering-Plough... [read post]
9 Aug 2008, 3:20 am
Letter from reader:I thought you might be interested in two potentially major problems with the recently released Schering Plough boceprevir data for the Sprint 1 trial. [read post]
29 May 2008, 10:26 am
Today in an SEC filing, Schering-Plough revealed that total prescriptions for disaster meds Vytorin and Zetia have dropped by more than 20% from January to April 2008.Total number of prescriptions were 3,205,000 in January and 2,492,000 in April.Most bloggers and commentators seem to think this is a dramatic drop.Reality is that Schering-Plough and Merck have so far been able to retain over 75% of their market. [read post]
30 Jul 2004, 1:16 pm
Drug manufacturer Schering-Plough Corp. agreed to a $345.5 million fine and to plead guilty that it overcharged the federal Medicaid program. [read post]
21 May 2009, 7:08 am
In the S-4 that Schering-Plough filed late yesterday they say this about Company X: Also during the January 9, 2009 Schering-Plough board update, Schering-Plough's financial advisors noted that another company ("Company X") potentially had the financial and operational capacity to complete a strategic transaction with Schering-Plough and that, other than Merck, Company X was, in their view, the entity most likely… [read post]
25 Jan 2008, 12:12 pm
Article in the Wall Street Journal -- Merck, Schering-Plough Defend Efforts for Vytorin, Zetia, by the Associated Press. [read post]
21 Jul 2008, 3:49 pm
Stock down 10%, then recoups all the losses by midday, then down 15% as Vytorin, an anti-cholesterol agent jointly sold by Merck & Co. and Schering-Plough Corp., failed to show it was effective in stopping progression of a cardiac condition known as aortic stenosis, a partial blockage of the heart's aortic valve, Norwegian researchers said Monday.Whew . . . what a roller coaster . . .But there's more:There were numerically more cancer deaths in the group of… [read post]
12 Mar 2007, 9:42 pm
Schering-Plough chairman and CEO Fred Hassan noted that the acquisition would give Schering-Plough immediate access to central nervous system... [read post]
21 Aug 2008, 6:02 pm
A congressional committee is demanding that the makers of controversial cholesterol drug Vytorin, Merck & Co. and Schering-Plough Corp., produce extensive data related to a clinical study indicating the drug might increase the risk of cancer.Rep. [read post]
29 Oct 2009, 7:56 am
On March 8, 2009, Schering-Plough proposed to acquire Merck and rename the surviving entity Merck. [read post]
10 Mar 2009, 10:26 am
Moreover, the Merck deal seems to depend on whether a reverse triangular merger can beat a control change clause in a Schering-Plough agreement... [read post]
30 Jun 2008, 1:50 pm
Hassan should step aside and let someone who knows run Schering-Plough? [read post]
20 Jun 2011, 9:15 am
At the end of its opinion, the Third Circuit blasted Schering-Plough's "chutzpah": Schering-Plough further complains that the IRS... [read post]
19 May 2008, 6:56 am
Or is it the 2007 Schering-Plough proxy that is untruthful? [read post]
19 Mar 2009, 2:18 pm
Subsidiary 1 will merge with and into Schering-Plough, paying its shareholders $10.50 in cash and 0.5767 of a share of Schering-Plough. [7] Finally, Merck will merge with subsidiary 2. [8] Each stock of Merck will be converted into a stock of Schering-Plough. [9] Thus, Merck will be a wholly-owned subsidiary of Schering-Plough, but Schering-Plough will take the name of Merck. [10] In other words, on paper a… [read post]
30 May 2007, 7:19 pm
By Jason Derry -- Novacea, Inc. and Schering-Plough have announced an agreement to develop and commercialize Asentar ®, which is currently in Phase III clinical trials for the treatment of prostate cancer. [read post]
